$13M sweet spot round size
Most of their 36 investments are in rounds between $3.5M and $38M
2009
QurAlis raised $88M on March 9, 2023
Investors: Sanofi Ventures, Life Sciences Partners (LSP), MP Healthcare Venture Management Inc, EQT Life Sciences, Mission BioCapital, Inkef and Mission Bay Capital
Nitrome Biosciences, Inc. raised $7M on November 2, 2021
Investors: Bristol-Myers Squibb, UK, The Dementia Discovery Fund, Sofinnova Partners and Mission Bay Capital
Nobell Foods raised $75M on July 22, 2021
Investors: AgFunder, New Crop Capital, Andreessen Horowitz, Hillhouse Capital Management, Breakthrough Energy Ventures and Mission Bay Capital
Symbiome raised $15M on September 14, 2020
Investors: GISEV Family Office, BOLD Capital Partners, True Ventures and Mission Bay Capital
Nitrome Biosciences, Inc. raised $38M on April 22, 2020
Investors: Sofinnova Partners, The Dementia Discovery Fund and Mission Bay Capital
Glycomine Inc. raised $33M on August 7, 2019
Investors: Chiesi Ventures, Sanderling Ventures, Mission BioCapital, Novo Holdings and Mission Bay Capital
GraphWear Technologies Inc. raised $4.2M on April 17, 2018
Investors: Mission BioCapital and Mission Bay Capital
Wildtype raised $3.5M on March 30, 2018
Investors: Root Ventures, For Good Ventures, Spark Capital and Mission Bay Capital
ViewPoint Therapeutics raised $35M on March 5, 2018
Investors: Lagunita Biosciences, Mission BioCapital and Mission Bay Capital
Pionyr Immunotherapeutics raised $62M on December 13, 2017
Investors: OrbiMed Advisors, Vida Ventures, LLC, Osage University Partners (OUP), Sofinnova Ventures, Russia technology fund, QB3 and Mission Bay Capital